Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Studies assess 2-year and sustained-release ONO-5334 therapy

Oct. 4, 2011

GlaxoSmithKline reports new SAP-binding proteins

Oct. 3, 2011

FDA reviews safety of drospirenone-containing birth control pills

Oct. 3, 2011

Biodel announces phase I data on experimental insulins

Sep. 30, 2011

Aegerion gives update on European filing for lomitapide

Sep. 30, 2011

Synageva BioPharma expands ongoing study in LAL deficiency

Sep. 30, 2011

Takeda files for approval of TAK-085 in Japan

Sep. 29, 2011

New PPAR-gamma agonists synthesized in Japan

Sep. 29, 2011

Denosumab shows long-term safety and efficacy in postmenopausal osteoporosis

Sep. 29, 2011

Long-term data presented on LB-03002 in children with growth hormone deficiency

Sep. 29, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...